Top compounds associated with response to LDLRAD3


Feature Type Standardized
Nominal ANOVA
mRNA spautin-1 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA DMOG GDSC1000 pan-cancer AAC -0.11 0.003
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.11 0.003
mRNA PD-0325901 CCLE pan-cancer AAC 0.14 0.003
mRNA JNK-9L GDSC1000 pan-cancer AAC -0.11 0.004
mRNA LBW242 CCLE pan-cancer AAC -0.15 0.004
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.11 0.004
mRNA AS601245 GDSC1000 pan-cancer AAC -0.11 0.004
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.11 0.004
Download CSV